Fortress Biotech, Inc.

NASDAQ:FBIO

Biotechnology

Healthcare
$1.77 -1.79%

-$0.06 today

Market cap
$59.03M
Beta
1.23
P/E (TTM)
0.7
EPS (TTM)
$4.05
52W Low $1.70High $4.53

Volume 0.19M

Average 0.43M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$65.78M

FY 2025 · Annual

Investing Cash Flow

$10.12M

FY 2025 · Annual

Financing Cash Flow

$77.44M

FY 2025 · Annual

+9.6% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(164.83M)(213.91M)(154.15M)(120.86M)(32.92M)
Depreciation & Amortization6.79M9.35M6M4.46M4.66M
Deferred Income Tax00000
Stock-Based Compensation19.49M22.99M17.03M32.62M28.74M
Change in Working Capital36.37M(715K)(12.52M)(8.13M)(25.1M)
Accounts Receivables834K(4.84M)12.52M4.47M(19.33M)
Inventory(8.46M)1.74M3.95M(4.23M)4.81M
Accounts Payables43.31M8.35M(24.38M)(6.39M)(7.97M)
Other Working Capital690K(5.97M)(4.61M)(1.98M)(2.6M)
Other Non-Cash Items(14.36M)2.89M15.42M11.71M(41.17M)
Operating Cash Flow(116.54M)(179.4M)(128.23M)(80.19M)(65.78M)
Capital Expenditures(16.35M)(3.06M)(8.1M)(15M)0
Acquisitions (Net)56.86M(20M)008.96M
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(11.78M)(213K)(2.04M)01.17M
Investing Cash Flow40.51M(22.93M)(2.1M)(15M)10.12M
Debt Repayment(9.64M)49.25M(38.79M)(7.33M)(5.64M)
Common Stock Issued155.26M40.26M80.38M82.84M84.63M
Common Stock Repurchased0(1.11M)00(265K)
Dividends Paid(8.78M)(8.78M)(8.77M)(4.71M)(664K)
Other Financing Activities(4.8M)(6.74M)(529K)(163K)(360K)
Financing Cash Flow148.99M75.32M32.74M70.64M77.44M
Effect of Forex Changes00000
Net Change in Cash72.97M(127.01M)(97.59M)(24.55M)21.79M
Free Cash Flow(132.89M)(182.46M)(136.32M)(95.19M)(65.78M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$32.9M
+ D&A$4.7M
+ Stock-Based Comp$28.7M
+ Deferred Tax$0
- Working Capital-$25.1M
- Other Non-Cash-$41.2M
= Operating Cash Flow-$65.8M
- Capex$0
= Free Cash Flow-$65.8M

Analysis

FY2025 free cash flow is -$65.8M. FCF conversion is 199.8% of net income. Operating cash flow was -$65.8M, with capex of $0. The largest bridge item is Other Non-Cash at -$41.2M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 13, 2026
SC 13G/ASC 13G/A filingOct 29, 2026
8-KCurrent reportOct 1, 2026
4Statement of changes in beneficial ownershipOct 1, 2026

Does FBIO generate free cash flow?

Fortress Biotech, Inc. (FBIO) generated -$65.78M of free cash flow in fiscal 2025.

How much operating cash flow does FBIO produce?

Operating cash flow was -$65.78M, before capital expenditures of $0.00.